Search research articles
Contact Us
Filters
Showing results (81-90 of 379) with videos related to
Page
of 38
Sort By:
Expert Review of Hematology
|
November 19, 2010
Hodgkin's lymphoma: current treatment strategies and novel approaches
Dennis A Eichenauer, Michael Fuchs, Peter Borchmann, et al.
Leukemia & Lymphoma
|
January 17, 2020
PET positivity - the agony of choice: response assessment and interpretation of increased FDG uptake of residual mediastinal tissue after frontline therapy in Hodgkin lymphoma
Sarah Gillessen, Carsten Kobe, Andreas Engert, et al.
The Cochrane Database of Systematic Reviews
|
October 21, 2015
Additional plerixafor to granulocyte colony-stimulating factors for haematopoietic stem cell mobilisation for autologous transplantation in people with malignant lymphoma or multiple myeloma
Tim Hartmann, Kai Hübel, Ina Monsef, et al.
The Cochrane Database of Systematic Reviews
|
August 12, 2011
Comparison of chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for patients with early unfavourable or advanced stage Hodgkin lymphoma
Kathrin Bauer, Nicole Skoetz, Ina Monsef, et al.
The Cochrane Database of Systematic Reviews
|
January 20, 2012
High-dose therapy with autologous stem cell transplantation versus chemotherapy or immuno-chemotherapy for follicular lymphoma in adults
Markus Schaaf, Marcel Reiser, Peter Borchmann, et al.
Journal of the National Cancer Institute
|
August 18, 2005
Third biannual report of the Cochrane Haematological Malignancies Group
Thilo Kober, Nicole Skoetz, Sven Trelle, et al.
Zeitschrift Fur Arztliche Fortbildung Und Qualitatssicherung
|
August 27, 2005
[Patient participation in the Cochrane Collaboration--barriers, experience, and concepts in Germany]
Olaf Weingart, Nicole Skoetz, Britta Lang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 20, 2007
CNS involvement in Hodgkin's lymphoma
Daniel Re, Michael Fuchs, Thomas Schober, et al.
Haematologica
|
July 20, 2004
Rituximab monotherapy is effective in patients with poor risk refractory aggressive non-Hodgkin's lymphoma
Achim Rothe, Holger Schulz, Thomas Elter, et al.
The Cochrane Database of Systematic Reviews
|
November 16, 2012
Role of chemotherapy additional to high-dose methotrexate for primary central nervous system lymphoma (PCNSL)
Nicole Bergner, Ina Monsef, Gerald Illerhaus, et al.
Page
of 38
Search research articles
Search
Showing results (81-90 of 379) with videos related to
Sort By:
Page
of 38
Expert Review of Hematology
|
November 19, 2010
Hodgkin's lymphoma: current treatment strategies and novel approaches
Dennis A Eichenauer, Michael Fuchs, Peter Borchmann, et al.
Leukemia & Lymphoma
|
January 17, 2020
PET positivity - the agony of choice: response assessment and interpretation of increased FDG uptake of residual mediastinal tissue after frontline therapy in Hodgkin lymphoma
Sarah Gillessen, Carsten Kobe, Andreas Engert, et al.
The Cochrane Database of Systematic Reviews
|
October 21, 2015
Additional plerixafor to granulocyte colony-stimulating factors for haematopoietic stem cell mobilisation for autologous transplantation in people with malignant lymphoma or multiple myeloma
Tim Hartmann, Kai Hübel, Ina Monsef, et al.
The Cochrane Database of Systematic Reviews
|
August 12, 2011
Comparison of chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for patients with early unfavourable or advanced stage Hodgkin lymphoma
Kathrin Bauer, Nicole Skoetz, Ina Monsef, et al.
The Cochrane Database of Systematic Reviews
|
January 20, 2012
High-dose therapy with autologous stem cell transplantation versus chemotherapy or immuno-chemotherapy for follicular lymphoma in adults
Markus Schaaf, Marcel Reiser, Peter Borchmann, et al.
Journal of the National Cancer Institute
|
August 18, 2005
Third biannual report of the Cochrane Haematological Malignancies Group
Thilo Kober, Nicole Skoetz, Sven Trelle, et al.
Zeitschrift Fur Arztliche Fortbildung Und Qualitatssicherung
|
August 27, 2005
[Patient participation in the Cochrane Collaboration--barriers, experience, and concepts in Germany]
Olaf Weingart, Nicole Skoetz, Britta Lang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 20, 2007
CNS involvement in Hodgkin's lymphoma
Daniel Re, Michael Fuchs, Thomas Schober, et al.
Haematologica
|
July 20, 2004
Rituximab monotherapy is effective in patients with poor risk refractory aggressive non-Hodgkin's lymphoma
Achim Rothe, Holger Schulz, Thomas Elter, et al.
The Cochrane Database of Systematic Reviews
|
November 16, 2012
Role of chemotherapy additional to high-dose methotrexate for primary central nervous system lymphoma (PCNSL)
Nicole Bergner, Ina Monsef, Gerald Illerhaus, et al.
Page
of 38